organophosphonates has been researched along with Cancer of Pelvis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asbury, RF; Blessing, JA; Soper, JT | 1 |
| Berg, GR; Kalisher, L; Osmond, JD; Pendergrass, HP; Potsaid, MS | 1 |
1 trial(s) available for organophosphonates and Cancer of Pelvis
| Article | Year |
|---|---|
A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix.
Topics: Adenine; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates; Pelvic Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms | 1994 |
1 other study(ies) available for organophosphonates and Cancer of Pelvis
| Article | Year |
|---|---|
99mTc-diphosphonate concentration in primary breast carcinoma.
Topics: Bone and Bones; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Humerus; Middle Aged; Neoplasm Metastasis; Organophosphonates; Pelvic Neoplasms; Radiography; Radionuclide Imaging; Technetium | 1973 |